Renaissance Technologies’s Oncolytics Biotech ONCY Stock Holding History

Renaissance Technologies’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$58.9K	Sell	62,010 -653,828	-91%	-$606K	﹤0.01%	3037
2026 Q1	$608K	Buy	+715,838	New	+$712K	﹤0.01%	2518
2023 Q2	–	Sell	-129,856	Closed	-$156K	–	4174
2023 Q1	$156K	Buy	129,856 +17,256	+15%	+$27.1K	﹤0.01%	3360
2022 Q4	$184K	Buy	112,600 +88,000	+358%	+$134K	﹤0.01%	3447
2022 Q3	$30K	Buy	24,600 +10,600	+76%	+$13K	﹤0.01%	3846
2022 Q2	$14K	Sell	14,000 -11,500	-45%	-$14K	﹤0.01%	4147
2022 Q1	$40K	Sell	25,500 -209,978	-89%	-$352K	﹤0.01%	3936
2021 Q4	$327K	Buy	235,478 +25,578	+12%	+$47.3K	﹤0.01%	3301
2021 Q3	$439K	Buy	209,900 +186,900	+813%	+$423K	﹤0.01%	2936
2021 Q2	$64K	Buy	+23,000	New	+$70.4K	﹤0.01%	3383
2021 Q1	–	Sell	-174,220	Closed	-$415K	–	3595
2020 Q4	$415K	Buy	174,220 +161,635	+1,284%	+$387K	﹤0.01%	2902
2020 Q3	$21K	Buy	+12,585	New	+$23.1K	﹤0.01%	3322
2020 Q2	–	Sell	-41,999	Closed	-$58K	–	3675
2020 Q1	$58K	Buy	+41,999	New	+$105K	﹤0.01%	3303
2019 Q4	–	Sell	-37,751	Closed	-$22K	–	3676
2019 Q3	$22K	Buy	+37,751	New	+$38.4K	﹤0.01%	3374
2018 Q4	–	Sell	-15,800	Closed	-$61K	–	3535
2018 Q3	$61K	Buy	+15,800	New	+$73.4K	﹤0.01%	3270

Other funds holding ONCY

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Seeds Investor New York $973M AUM 33.7% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

TAM

Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return

EFG

Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return

Renaissance Technologies's ONCY Position: Q2 2026 in Review

Renaissance Technologies reduced its Oncolytics Biotech (ONCY) stake by 91% in Q2 2026, selling an estimated $606K and leaving 62,010 shares worth $58.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3037.

Renaissance Technologies first reported a position in ONCY in Q3 2018 and has held it in 15 quarters since. The position peaked at $608K in Q1 2026. 75 funds tracked by Wall St. Rank hold ONCY as of Q2 2026.

Renaissance Technologies held 62,010 shares of Oncolytics Biotech worth $58.9K as of Q2 2026.
Renaissance Technologies sold 653,828 Oncolytics Biotech shares in Q2 2026, an estimated $606K.
Oncolytics Biotech made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #3037 holding.
Renaissance Technologies first reported a position in Oncolytics Biotech in Q3 2018 and has held it in 15 quarters since.
Renaissance Technologies's Oncolytics Biotech position peaked at $608K in Q1 2026.
75 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.